{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:40:04Z","timestamp":1786992004546,"version":"build-2736575974"},"reference-count":5,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdcjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jdiacomp.2016.08.002","type":"journal-article","created":{"date-parts":[[2016,8,14]],"date-time":"2016-08-14T15:08:53Z","timestamp":1471187333000},"page":"1530-1531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Possible new inflammatory side-effect of SGLT2-inhibitors: Fixed drug eruption"],"prefix":"10.1016","volume":"30","author":[{"given":"Giovanni","family":"Damiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulvi","family":"Loite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ramoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Valerio","family":"Marzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jdiacomp.2016.08.002_bb0005","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1684\/ejd.2010.0980","article-title":"A three-year-analysis of fixed drug eruptions in hospital settings in France","volume":"20","author":"Brahimi","year":"2010","journal-title":"European Journal of Dermatology: EJD"},{"issue":"1","key":"10.1016\/j.jdiacomp.2016.08.002_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00281-015-0540-2","article-title":"Adverse cutaneous drug eruptions: Current understanding","volume":"38","author":"Hoetzenecker","year":"2016","journal-title":"Seminars in Immunopathology"},{"issue":"7","key":"10.1016\/j.jdiacomp.2016.08.002_bb0015","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1185\/03007995.2012.697053","article-title":"Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor","volume":"28","author":"Nyirjesy","year":"2012","journal-title":"Current Medical Research and Opinion"},{"issue":"1","key":"10.1016\/j.jdiacomp.2016.08.002_bb0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000443949","article-title":"Fixed drug eruption due to achiote dye","volume":"8","author":"Tattersall","year":"2016","journal-title":"Case Reports in Dermatology"},{"key":"10.1016\/j.jdiacomp.2016.08.002_bb0025","doi-asserted-by":"crossref","DOI":"10.2174\/1574886311666160405110515","article-title":"Generalized intense pruritus during canagliflozin treatment: Is it an adverse drug reaction?","author":"Vasapollo","year":"2016","journal-title":"Current Drug Safety"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872716303440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872716303440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T01:08:35Z","timestamp":1600996115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872716303440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":5,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1056872716303440"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.08.002","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possible new inflammatory side-effect of SGLT2-inhibitors: Fixed drug eruption","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}